Opinion: STAT+: Former Geisinger CEO: U.S. health systems must replace huge numbers of people with AI 

Resarchers say Merck should 'urgently begin licensing generic production to its HIV prevention pill.

The researchers identified a driving force behind the condition, opening up a potential target for new therapies.

From tariffs to incentives, the administration wants to push companies to manufacture drugs in the U.S.

For researcher Maiken Nedergaard, ‘diseases of aging are basically all about dirty brains’